Embryonal rhabdomyosarcoma of the epididymis presenting as epididymitis: A case report

  • Authors:
    • Hong‑Liang Wang
    • Ling‑Yun Liu
    • Run‑Hui Tian
    • Fu‑Biao Li
    • Kai‑Min Guo
  • View Affiliations

  • Published online on: January 18, 2016     https://doi.org/10.3892/mco.2016.733
  • Pages: 625-627
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Paratesticular rhabdomyosarcoma (RMS) is an extremely rare malignancy in adults, accounting for 7% of all RMS cases and 6% of all non‑germinal intrascrotal tumors. The clinical signs are similar to those of a hydrocele or testicular tumor, typically presenting as a unilateral, painless mass in the inguinal canal or scrotum. No specific serum markers are currently available for this tumor. RMS of the epididymis is extremely rare. Particularly when it is associated with epididymitis, this malignancy is usually overlooked. we herein present a case of epididymal embryonal RMS, manifesting an painful scrotal edema, misdiagnosed as epididymitis. The patient received 3 cycles of adjuvant chemotherapy postoperatively and remained disease‑free after 4 years of follow‑up.
View Figures
View References

Related Articles

Journal Cover

April 2016
Volume 4 Issue 4

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, H., Liu, L., Tian, R., Li, F., & Guo, K. (2016). Embryonal rhabdomyosarcoma of the epididymis presenting as epididymitis: A case report. Molecular and Clinical Oncology, 4, 625-627. https://doi.org/10.3892/mco.2016.733
MLA
Wang, H., Liu, L., Tian, R., Li, F., Guo, K."Embryonal rhabdomyosarcoma of the epididymis presenting as epididymitis: A case report". Molecular and Clinical Oncology 4.4 (2016): 625-627.
Chicago
Wang, H., Liu, L., Tian, R., Li, F., Guo, K."Embryonal rhabdomyosarcoma of the epididymis presenting as epididymitis: A case report". Molecular and Clinical Oncology 4, no. 4 (2016): 625-627. https://doi.org/10.3892/mco.2016.733